Copay Assistance From The Assistance Fund Now Available for Eligible People Living With Acute Myeloid Leukemia

ORLANDO, Fla., April 16, 2019 /PRNewswire/ -- The Assistance Fund, an independent charitable patient assistance foundation that helps patients and families facing high medical out-of-pocket costs, today announced the launch of a new copay assistance program designed to help people living with Acute Myeloid Leukemia (AML).

Acute Myeloid Leukemia, the most common type of leukemia in adults, is a cancer of the blood and bone marrow. Bone marrow typically makes blood stem cells that become mature blood cells over time: myeloid stem cells or lymphoid stem cells. With AML, myeloid stem cells often become immature, abnormal white blood cells called myeloblasts. Myeloblasts build up in the blood and bone marrow, leaving less room for healthy white blood cells, red blood cells and platelets, and can spread to other parts of the body.[1] The American Cancer Society estimates doctors will diagnose about 21,450 new AML cases in America in 2019.

"People living with AML should only have to think about one goal: achieving remission," said Mark P. McGreevy, president and CEO, The Assistance Fund. "Thanks to our generous donors, this new copay program alleviates the financial burden faced by underinsured people living with AML and allows them to focus on getting critical treatment."

To learn more about The Assistance Fund or to determine eligibility for financial support, visit tafcares.org or call (855) 684-4608 to speak with a patient advocate.

A complete list of The Assistance Fund's programs is available at tafcares.org.

About The Assistance Fund
The Assistance Fund is an independent charitable patient assistance foundation that helps patients and families facing high medical out-of-pocket costs by providing financial assistance for their copayments, coinsurance, deductibles and other health-related expenses. The Assistance Fund currently manages more than 60 programs – each of which covers the FDA-approved medications that treat a specific disease. Since its founding in 2009, The Assistance Fund has helped more than 78,000 adults and children access the medicines they need to stay healthy or manage a chronic condition. To learn more about The Assistance Fund or for information on how to donate, please visit tafcares.org.

Media Contact:
Margaret Figley, Director of Communications
[email protected]

References:
[1] "Acute Myeloid Leukemia." The American Association for Cancer Research. (April 15, 2019). Retrieved from: https://www.aacrfoundation.org/CancerTypes/Pages/Acute-Myeloid-Leukemia.aspx

Related Links

The Assitance Fund

SOURCE The Assistance Fund

Related Links

http://www.tafcares.org